May. 15 at 7:48 PM
Precipio, Inc. (Nasdaq:
$PRPO), a specialty cancer diagnostics company, reported first quarter 2026 financial results, with revenue growing 36% year-over-year to
$6.71 million.
Precipio, Inc. - Nasdaq: PRPO, is a B2i Digital Featured Company. See the company’s profile at b2idigital.com/precipio-inc-1 and follow Precipio on X, LinkedIn, and Facebook.
Q1 2026 Financial Highlights:
• Revenue of
$6.71 million, up 36% from
$4.93 million in Q1 2025
• Positive operating cash flow of
$60,000 during the quarter
• Expanding product pipeline generated by the company’s newly hired commercial team
• Q1 2026 shareholder update call scheduled for Monday, May 18, 2026 at 5:00 PM Eastern, including live Q&A
Ilan Danieli, Chief Executive Officer of Precipio, noted, “The underlying business fundamentals continue to grow, in particular the product pipeline that has been generated by our newly hired commercial team.”
Conference Call Details: Monday, May 18, 2026 at 5:00 PM Eastern. Dial-in: 646.307.1865 (callers should ask for the Precipio Inc. conference call). Live Q&A will follow management remarks; questions may also be submitted in advance to
[email protected]. A replay will be posted approximately 24 hours after the call at precipiodx.com/investors.
Read the full press release: https://www.precipiodx.com/precipio-announces-q1-2026-financial-results/
Precipio is a healthcare biotechnology company focused on cancer diagnostics. Its mission is to address the problem of cancer misdiagnoses by developing diagnostic products and services designed to deliver greater accuracy, improved laboratory workflow, and better patient outcomes. Precipio develops, validates, and clinically uses these technologies in its laboratory before commercializing them as proprietary products for the global laboratory community.
More information is at precipiodx.com. Investor inquiries:
[email protected], +1-203-787-7888 Ext. 523.
Disclosure: This post is informational only and is not an offer or solicitation regarding any security. See the complete Disclosure at b2idigital.com/disclaimer. B2i Digital is not a broker-dealer or investment adviser.
